BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31289144)

  • 41. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).
    Wrobe D; Henseler M; Huettler S; Pascual Pascual SI; Chabas A; Sandhoff K
    J Inherit Metab Dis; 2000 Feb; 23(1):63-76. PubMed ID: 10682309
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Diagnostic strategy of metachromatic leukodystrophy in Tunisia].
    Barboura I; Chebel S; Ferchichi S; Ben Mansour R; Frih-Ayed M; Miled A
    Ann Biol Clin (Paris); 2011; 69(4):465-9. PubMed ID: 21896413
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adult form of metachromatic leukodystrophy with predominantly psychotic manifestations].
    Penzien JM; Herschkowitz N; Gieselmann V
    Nervenarzt; 1994 Jan; 65(1):73. PubMed ID: 8145880
    [No Abstract]   [Full Text] [Related]  

  • 44. CT and MRI in late-onset metachromatic leukodystrophy.
    Reider-Grosswasser I; Bornstein N
    Acta Neurol Scand; 1987 Jan; 75(1):64-9. PubMed ID: 3577670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infantile metachromatic leukodystrophy: deficiency of arylsulfatase A in skin fibroblasts: heterozygote detection.
    Kaback M
    Birth Defects Orig Artic Ser; 1971 Feb; 7(1):239. PubMed ID: 5317490
    [No Abstract]   [Full Text] [Related]  

  • 46. Two novel mutations in the arylsulfatase A gene associated with juvenile (R390Q) and adult onset (H397Y) metachromatic leukodystrophy.
    Coulter-Mackie MB; Gagnier L
    Hum Mutat; 1998; Suppl 1():S254-6. PubMed ID: 9452102
    [No Abstract]   [Full Text] [Related]  

  • 47. Identification of two novel arylsulfatase A mutations with a polymorphism as a cause of metachromatic leukodystrophy.
    Onder E; Sinici I; Müjgan Sönmez F; Topçu M; Ozkara HA
    Neurol Res; 2009 Feb; 31(1):60-6. PubMed ID: 18768108
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sulfatide excreting heterozygous carrier of juvenile metachromatic leukodystrophy or asymptomatic patient of adult metachromatic leukodystrophy.
    Harzer K; Recke AS
    Humangenetik; 1975 Oct; 29(4):299-307. PubMed ID: 1176145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metachromatic leukodystrophy. Report of siblings with the juvenile type of metachromatic leukodystrophy.
    Satoh T; Suzuki H; Monma N; Satodate R; Tanaka H; Yajima H
    Acta Pathol Jpn; 1988 Aug; 38(8):1041-51. PubMed ID: 3188912
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Juvenile metachromatic leukodystrophy: understanding the disease and implications for nursing care.
    Barrell C
    J Pediatr Oncol Nurs; 2007; 24(2):64-9. PubMed ID: 17332420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Late-Onset Metachromatic Leukodystrophy with Early Onset Dementia Associated with a Novel Missense Mutation in the Arylsulfatase A Gene.
    Stoeck K; Psychogios MN; Ohlenbusch A; Steinfeld R; Schmidt J
    J Alzheimers Dis; 2016; 51(3):683-7. PubMed ID: 26890752
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sphingolipid activator protein B deficiency: report of 9 Saudi patients and review of the literature.
    Al-Hassnan ZN; Al Dhalaan H; Patay Z; Faqeih E; Al-Owain M; Al-Duraihem A; Faiyaz-Ul-Haque M
    J Child Neurol; 2009 Dec; 24(12):1513-9. PubMed ID: 19955343
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presymptomatic diagnosis: metachromatic leukodystrophy or pseudo arylsulphatase A deficiency?
    Kihara H; Fluharty AL; Ng WG; Leider W
    J Inherit Metab Dis; 1982; 5(4):215-7. PubMed ID: 6133034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metachromatic leukodystrophy with late adult-onset: diagnostic clues and differences from other genetic leukoencephalopathies with dementia.
    Benzoni C; Moscatelli M; Fenu S; Venerando A; Salsano E
    J Neurol; 2021 May; 268(5):1972-1976. PubMed ID: 33417004
    [No Abstract]   [Full Text] [Related]  

  • 55. [Metachromatic leukodystrophy (MLD) and Multiple sulphatase deficiency (MSD)].
    Eto Y; Hasegawa Y; Tsuda T
    Nihon Rinsho; 1995 Dec; 53(12):2994-3003. PubMed ID: 8577048
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Prosaposin deficiency].
    Kondoh K; Sano A
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):414-6. PubMed ID: 9645096
    [No Abstract]   [Full Text] [Related]  

  • 57. Slowly Progressive Psychiatric Symptoms: Think Metachromatic Leukodystrophy.
    van Rappard DF; de Vries ALC; Oostrom KJ; Boelens JJ; Hollak CEM; van der Knaap MS; Wolf NI
    J Am Acad Child Adolesc Psychiatry; 2018 Feb; 57(2):74-76. PubMed ID: 29413149
    [No Abstract]   [Full Text] [Related]  

  • 58. [Metachromatic leukodystrophy with a familial incidence; prenatal diagnosis].
    Pijácková A; Kaláb Z; Machill G; Sachs E; Macek M; Podhradská O; Kaspárková Z; Dvorák K
    Cesk Pediatr; 1985 May; 40(5):288-90. PubMed ID: 4017079
    [No Abstract]   [Full Text] [Related]  

  • 59. Novel mutations in arylsulfatase A gene in three Ukrainian families with metachromatic leukodystrophy.
    Olkhovich NV; Takamura N; Pichkur NA; Gorovenko NG; Aoyagi K; Yamashita S
    Mol Genet Metab; 2003 Nov; 80(3):360-3. PubMed ID: 14680985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Metachromatic Leukodystrophy (MLD): MRI findings].
    Fenchel M; Hauser TK; Nägele T; Ernemann U; Horger M
    Rofo; 2011 Oct; 183(10):893-5. PubMed ID: 22232791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.